VIENNA — Intravitreal aflibercept injection with an individualized treat-and-extend schedule is a positive approach to macular edema secondary to central retinal vein occlusion, according to a study presented at the Euretina meeting.
“Fixed and PRN regimens lead to significant discomfort and cost, while T&E has a more flexible schedule for follow-up visits, depending on the individual evolution of the disease. It is a proactive treatment regimen that allows early re-treatment of the lesion before reactivation and eventually results in fewer injections and fewer visits,”
Uncategorized